Web Analytics

3 Latest Announced Rounds

  • $3,500,000
    Seed

    1 Investors

    Technology, Information and Internet
    Dec 20th, 2024
  • $5,619,170
    Series B

    1 Investors

    Research Services
    Dec 20th, 2024
  • $8,000,000
    Unknown

    5 Investors

    Computer & Network Security
    Dec 20th, 2024
$671.88M Raised in 44 Funding Rounds in the past 7 Days - View All

Funding Round Profile

STMPatch

start up
United States - Farmington, Connecticut
  • 15/02/2024
  • Pre-Seed
  • Undisclosed Amount

The SingleTimeMicroneedle Patch allows vaccines to be delivered via transdermal patch that painlessly embeds bodily degradable microneedles in the skin. The microneedles can be programmed for delivery over time and at specific times, requires no refrigeration, and can be self-administered by patients.

The core technology of STM is a vaccine patch which can be painlessly applied at a single time on the skin to embed arrays of microneedles (MNs) inside the superficial skin layer (like an invisible tattoo). The MNs are made of a safe biodegradable polymer (used for surgical suture) and pre-programmed to release vaccines repeatedly over a long period, mimicking the effect of multiple prime/booster doses in the traditional vaccination process. The vaccines (including subunit protein-based antigen, vector-based vaccine or mRNAs) are stabilized against high temperatures, thus avoiding the need of cold-chain storage facilities and affirming the antigenicity for a long-term skin embedment. The technology will revolutionize the vaccination process by (1) enabling a high immunogenic efficacy via transdermal delivery, (2) enhancing patient compliance via the use of painless and self-administered skin patch, and (3) removing the logistic/economic burden to store vaccines at high temperatures. This skin patch could also be applied for animal vaccination, offering a high impact on both healthcare and other industry sectors.


Related People

Jasdeep SinghFounder

Jasdeep Singh United States - Farmington, Connecticut

As the Chief Executive Officer of STMPatch, I lead a team of passionate and talented professionals who are democratizing the delivery of transdermal medicines with SingleTimeMicroneedle's patches. My work combines science with a pro-profit, do-better-for society business model that strives to improve community health around the globe.
With over a decade of experience in the fields of business development, organizational leadership, and market analysis, I bring an informed and creative perspective to the healthcare, veterinary, science, and tech industries. As a former educator, I understand the importance of putting people first, empowering leaders, and supporting growth in all its forms.
I am driven by the mission of improving the lives of patients and consumers with innovative and affordable solutions. As a learner at heart, I have worked with over 30 companies, many associated with UConn, led or consulted for four tech-transfer companies, and held leadership positions in both public and private organizations.